ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Public ClinicalTrials.gov record NCT03594227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 2, multicenter, randomized study will evaluate the safety, tolerability and efficacy of ATI-501 for the treatment of Alopecia Areata (AA), Alopecia Universalis (AU) or Alopecia Totalis (AT) in adult subjects.
Study identification
- NCT ID
- NCT03594227
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Interventions
- ATI-501 400mg BID (Low dose) Drug
- ATI-501 600mg BID (Mid dose) Drug
- ATI-501 800mg BID (High dose) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 11, 2018 (Actual)
- Primary completion
- Jun 6, 2019 (Actual)
- Completion
- Jun 18, 2019 (Actual)
- Last update posted
- Sep 16, 2020
2018 – 2019
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aclaris Investigator Site | Hot Springs | Arkansas | 71913 | — |
| Aclaris Investigator Site | Rogers | Arkansas | 72758 | — |
| Aclaris Investigator Site | Denver | Colorado | 80210 | — |
| Aclaris Investigator Site | Boynton Beach | Florida | 33472 | — |
| Aclaris Investigator Site | Miami | Florida | 33137 | — |
| Aclaris Investigator Site | Sanford | Florida | 32771 | — |
| Aclaris Investigator Site | Snellville | Georgia | 30078 | — |
| Aclaris Investigator Site | Clinton Township | Michigan | 48038 | — |
| Aclaris Investigator Site | Detroit | Michigan | 48202 | — |
| Aclaris Investigator Site | Fridley | Minnesota | 55432 | — |
| Aclaris Investigator Site | Minneapolis | Minnesota | 55455 | — |
| Aclaris Investigator Site | Saint Joseph | Missouri | 64506 | — |
| Aclaris Investigator Site | Omaha | Nebraska | 68144 | — |
| Aclaris Investigator Site | Las Vegas | Nevada | 89148 | — |
| Aclaris Investigator Site | New York | New York | 10075 | — |
| Aclaris Investigator Site | Rochester | New York | 14623 | — |
| Aclaris Investigator Site | Portland | Oregon | 97223 | — |
| Aclaris Investigator Site | Greenville | South Carolina | 29607 | — |
| Aclaris Investigator Site | Knoxville | Tennessee | 37922 | — |
| Aclaris Investigator Site | Nashville | Tennessee | 37215 | — |
| Aclaris Investigational Site | Austin | Texas | 78745 | — |
| Aclaris Investigator Site | Houston | Texas | 77056 | — |
| Aclaris Investigator Site | San Antonio | Texas | 78213 | — |
| Aclaris Investigator Site | Lynchburg | Virginia | 24501 | — |
| Aclaris Investigator Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03594227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2020 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03594227 live on ClinicalTrials.gov.